Vanguard Health Care ETF (VHT)
155.00
-0.87 -0.56%
NYSE Arca
Apr 20, 12:40
Delayed 2m
USD
VHT Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
View All VHT News
VHT News
-
WireHeadlineTime (ET)
-
MT Newswires04/20 08:46
-
MT Newswires04/19 13:28
-
SA Breaking News04/19 11:25
-
MT Newswires04/19 09:21
-
MT Newswires04/18 13:30
-
MT Newswires04/18 09:20
-
MT Newswires04/17 13:50
-
MT Newswires04/17 09:13
-
MT Newswires04/16 13:41
-
MT Newswires04/16 09:16
VHT Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | -1.67% | -1.62% | -1.98% | 60 |
| 3M | -5.03% | -4.99% | -0.92% | 74 |
| 6M | 1.17% | 1.20% | 4.35% | 53 |
| YTD | 1.37% | 1.42% | 4.26% | 64 |
| 1Y | 16.52% | 16.56% | 19.27% | 49 |
| 3Y | 6.22% | 6.24% | 3.47% | 21 |
| 5Y | 14.35% | 14.36% | 14.89% | 45 |
| 10Y | 12.92% | 12.91% | 13.29% | 53 |
VHT Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.36% | 0.36% | 0.00% |
| Stock | 99.64% | 99.64% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.01% | 0.01% | 0.00% |
VHT Region Exposure
| Americas | 99.85% |
| North America | 99.83% |
| Latin America | 0.02% |
| Greater Europe | 0.14% |
| United Kingdom | 0.10% |
| Europe Developed | 0.04% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.01% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.01% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.00% |
| % Emerging Markets | 0.00% |
VHT Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.03% |
| Healthcare | 98.46% |
| Industrials | 0.05% |
| Real Estate | 0.00% |
| Technology | 1.45% |
| Utilities | 0.00% |
VHT Stock Market Capitalization
| Giant | 48.58% |
| Large | 32.92% |
| Medium | 12.46% |
| Small | 5.34% |
| Micro | 0.70% |
VHT Stock Style Exposure
| Large Cap Value | 32.39% |
| Large Cap Blend | 22.67% |
| Large Cap Growth | 26.59% |
| Mid Cap Value | 0.86% |
| Mid Cap Blend | 3.14% |
| Mid Cap Growth | 8.49% |
| Small Cap Value | 0.47% |
| Small Cap Blend | 1.85% |
| Small Cap Growth | 3.54% |
View More Holdings
As of March 31, 2018
VHT Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 9.51% | 126.45 | -0.86% |
| PFE | Pfizer Inc | 5.84% | 36.64 | +0.30% |
| UNH | UnitedHealth Group Inc | 5.73% | 234.12 | -0.70% |
| ABBV | AbbVie Inc | 4.17% | 92.95 | -0.06% |
| MRK | Merck & Co Inc | 4.10% | 58.81 | +0.29% |
| AMGN | Amgen Inc | 3.17% | 171.81 | -0.65% |
| MDT | Medtronic PLC | 3.00% | 79.86 | -0.18% |
| ABT | Abbott Laboratories | 2.88% | 59.08 | -1.34% |
| BMY | Bristol-Myers Squibb Company | 2.86% | 51.43 | -0.35% |
| GILD | Gilead Sciences Inc | 2.72% | 73.29 | -1.54% |
Advertisement
VHT One Page Reports
- One Page Report Download
VHT Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Blend |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Vanguard |
| Benchmark Index | |
|---|---|
MSCI US IMI/Health Care 25-50 GR USD |
100.0% |
VHT Manager Info
| Name | Tenure |
|---|---|
| Michelle Louie | 0.00 yrs |
| Walter Nejman | 1.94 yrs |
VHT Net Fund Flows
| 1M | -10.86M |
| 3M | -17.78M |
| 6M | 17.63M |
| YTD | -17.78M |
| 1Y | 460.92M |
| 3Y | 1.276B |
| 5Y | 4.102B |
| 10Y | 4.613B |
VHT Risk Info
| Beta (5Y) | 0.9247 |
| Max Drawdown (All) | 39.01% |
| Historical Sharpe (10Y) | 0.923 |
| Historical Sortino (All) | 0.9062 |
| 30-Day Rolling Volatility | 20.54% |
| Daily Value at Risk (VaR) 1% (All) | 2.90% |
| Monthly Value at Risk (VaR) 1% (All) | 12.92% |
VHT Fundamentals
| Dividend Yield TTM (4-20-18) | 1.96% |
| SEC Yield (4-18-18) | 1.45% |
| Weighted Average PE Ratio | 26.25 |
| Weighted Average Price to Sales Ratio | 1.890 |
| Weighted Average Price to Book Ratio | 3.913 |
| Weighted Median ROE | 14.07% |
| Weighted Median ROA | 3.23% |
| Forecasted Dividend Yield | 1.55% |
| Forecasted PE Ratio | 15.79 |
| Forecasted Price to Sales Ratio | 1.751 |
| Forecasted Price to Book Ratio | 3.471 |
| Number of Holdings | 363 |
VHT Growth Estimates
| Forecasted 5 Yr Earnings Growth | 11.03% |
| Forecasted Book Value Growth | 6.53% |
| Forecasted Cash Flow Growth | 7.20% |
| Forecasted Earnings Growth | 0.65% |
| Forecasted Revenue Growth | 8.01% |
VHT Attributes
| Key Dates | |
|---|---|
| Inception Date | 1/26/2004 |
| Termination Date | |
| Last Annual Report Date | 8/31/2017 |
| Last Prospectus Date | 12/21/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
VHT Excel Add-In Codes
- Name: =YCI("VHT","name")
- Broad Asset Class: =YCI("VHT", "broad_asset_class")
- Broad Category: =YCI("VHT", "broad_category_group")
- Prospectus Objective: =YCI("VHT", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
